Dermal Filler 1ml (Restylane/Stylage)

A 1ml hyaluronic acid filler treatment using Restylane or Stylage for facial contouring, volume restoration, and wrinkle correction. Suitable for cheeks, nasolabial folds, jawline, chin, and tear troughs depending on the specific product selected.

This treatment provides 1ml of premium cross-linked hyaluronic acid filler from established European brands — Restylane (Galderma) or Stylage (Vivacy) — applied to the facial area requiring volume restoration or contouring. The specific product is selected based on the treatment zone: firmer, more cohesive gels for structural areas like the cheeks and jawline, and softer, more pliable formulations for delicate areas like tear troughs and fine lines. Restylane is one of the world's most widely used dermal filler ranges, with over 50 million treatments performed globally. Its NASHA (Non-Animal Stabilised Hyaluronic Acid) technology produces a consistent, well-characterised gel. Stylage, manufactured by French laboratory Vivacy, uses IPN-Like technology (Interpenetrating Network) which combines two molecular weights of HA for enhanced longevity and a natural feel in tissue. Common treatment areas include the malar (cheek) region for volume restoration and mid-face lift, nasolabial folds (nose-to-mouth lines), marionette lines (mouth-to-chin), jawline definition and contouring, chin projection, and tear trough hollowing. Each area requires different injection depths, techniques, and product viscosities, which is why the practitioner selects the appropriate variant from the Restylane or Stylage range for each case. The procedure takes approximately 30 minutes including anaesthetic application and injection. Results are immediately visible, with the final appearance settling over 1-2 weeks as the filler integrates with surrounding tissue and any swelling resolves. Duration of effect varies by area: structural zones like cheeks and jawline typically retain results for 12-18 months, while high-movement areas like nasolabial folds may require retreatment at 8-12 months. At 1,200 PLN (approximately €280), this pricing undercuts comparable treatments in Germany (€350-500 per ml) and Austria (€400-600 per ml) by a significant margin while using identical products available across the EU.